Widely prescribed, newer-generation antipsychotic drugs are no more effective for the treatment of schizophrenia in children and teens than older, cheaper drugs, a government-funded study shows.
Under the direction of the National Institute of Mental Health (NIMH), researchers compared two of the newer drugs, known as atypical antipsychotics, to an older-generation antipsychotic. They found no major differences in treatment outcomes, but big differences in side effects among young patients taking the newer and older drugs.
Newer Antipsychotics No Better in Kids
A nationwide, successful teen pregnancy prevention program is being eliminated under President Donald Trump's proposed FY...
Diseases rarely seen in modern society are popping back up in Italy and elsewhere in Europe,...
Cigarette manufacturers are attempting to thwart government tobacco controls wherever possible, even as governments make progress...
